ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Breakthrough bleeding and breakthrough bleeding/spotting by cycle for the ethinyl estradiol and norelgestromin contraceptive patch

Breakthrough bleeding and breakthrough bleeding/spotting by cycle for the ethinyl estradiol and norelgestromin contraceptive patch
  Noncomparative trial Comparative trial
Patch* (n = 1664), percent Patch* (n = 812), percent OC (n = 605), percent
Breakthrough bleeding
Cycle 1 3.7 3.7 4.2
Cycle 3 3.7 2.9 4.5
Cycle 6 2.5 2.7 3.0
Cycle 9 1.5 1.3 3.1
Cycle 13 1.7 0 2.4
Breakthrough bleeding and/or spotting
Cycle 1 17.5 18.3 11.4
Cycle 3 11.1 10.0 8.8
Cycle 6 7.3 9.5 7.1
Cycle 9 6.5 6.7 4.6
Cycle 13 9.2 5.5 7.1
OC: oral contraceptive.
* Patch: Ethinyl estradiol and norelgestromin transdermal contraceptive patch.
¶ OC: Triphasic preparation with levonorgestrel as progestin.
Adapted with permission from: Burkman RT. The transdermal contraceptive patch: a new approach to hormonal contraception. Int J Fertil Womens Med. 2002; 47(2): 69-76. Copyright © 2002 MSP International, Inc.
Graphic 64067 Version 6.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟